Welcome to Skin cancer and Mesothelioma Cancer

Mesothelioma Cancer, Melanoma Cancer, Mesothelioma, Mesothelioma Lawyer
==================================================================

Thursday, July 17, 2008

Fwd: Students Must "Borrow Smart" in the Midst of Financial Aid Crisis, According to Experts at CollegeWeekLive (Broadcast Newsroom)



---------- Forwarded message ----------
From: Yahoo! News Search Results for college loan consolidation <rssfwd@rssfwd.com>
Date: Wed, Jul 16, 2008 at 7:44 AM
Subject: Students Must "Borrow Smart" in the Midst of Financial Aid Crisis, According to Experts at CollegeWeekLive (Broadcast Newsroom)
To: mesothelioma77@gmail.com


BOSTON, MA -- (MARKET WIRE) -- 07/14/08 -- Last week on July 10, 2008, CollegeWeekLive(TM) hosted CollegeWeekLive: "Paying for College," the first-ever, major online event focused on addressing families' needs and challenges in financing higher education.

Mon, 14 Jul 2008 12:50:37 GMT

___
Source: http://us.rd.yahoo.com/dailynews/rss/search/college+loan+consolidation/SIG=127lib6cc/*http%3A//www.broadcastnewsroom.com/articles/viewarticle.jsp?id=452042
--
 ~
Powered by [4]RssFwd, a service of [5]Blue Sky Factory, Inc

 

Fwd: A rebuttal: Secret ties to industry and conflicting interests in cancer research, March 2007;50(3):227-233.



---------- Forwarded message ----------
From: HubMed - cancer <rssfwd@rssfwd.com>
Date: Wed, Jul 16, 2008 at 9:21 AM
Subject: RE: A rebuttal: Secret ties to industry and conflicting interests in cancer research, March 2007;50(3):227-233.
To: mesothelioma77@gmail.com


[1]Am J Ind Med. 2008 Jul 14;
Hardell L, Walker MJ, Walhjalt B





___
Source: http://www.hubmed.org/display.cgi?uids=18626889
--
 Powered by [5]RssFwd, a service of [6]Blue Sky Factory, Inc

 

Fwd: News & Star (The News and Star)



---------- Forwarded message ----------
From: Yahoo! News Search Results for asbestos cancer <rssfwd@rssfwd.com>
Date: Wed, Jul 16, 2008 at 9:21 AM
Subject: News & Star (The News and Star)
To: mesothelioma77@gmail.com


An official investigation will be launched today into claims that Carlisle Housing Association has flouted rules on handling deadly asbestos. The allegations were highlighted in dramatic fashion when Carlisle City Council met last night.

Wed, 16 Jul 2008 11:54:16 GMT

___
Source: http://us.rd.yahoo.com/dailynews/rss/search/asbestos+cancer/SIG=11e7crdeb/*http%3A//www.newsandstar.co.uk/news/1.204098
--
 ~
Powered by [4]RssFwd, a service of [5]Blue Sky Factory, Inc

 

Fwd: Mental Adjustment to Cancer Scale((c)): psychometric properties in a large cancer cohort.



---------- Forwarded message ----------
From: HubMed - cancer <rssfwd@rssfwd.com>
Date: Wed, Jul 16, 2008 at 9:21 AM
Subject: Mental Adjustment to Cancer Scale((c)): psychometric properties in a large cancer cohort.
To: mesothelioma77@gmail.com


[1]Psychooncology. 2008 Jul 14;
Watson M, Homewood J

Objectives: The Mental Adjustment to Cancer (MAC) Scale is widely used to assess psychological response to cancer. There have been several attempts to replicate independently the original factor structure of the MAC. Evidence from these replication studies is reviewed. A re-analysis of the MAC Scale was conducted on a substantial new cohort in order to clarify the factor structure.Methods: 1255 patients with various cancer diagnoses completed the MAC Scale.Results: Two results emerged: first, that the original MAC dimension of Helplessness/Hopelessness is extremely stable and robust; second, that the original factors can be subsumed within two overarching (first order) factors relating to positive and negative adjustment scores.Conclusions: The original MAC Scale remains a satisfactory measure of psychological outcome. Two-higher order factors representing global adjustment are now available to provide an overall summary measure alongside the original specific sub-scales. Copyright (c) 2008 John Wiley & Sons, Ltd.



___
Source: http://www.hubmed.org/display.cgi?uids=18626853
--
 Powered by [5]RssFwd, a service of [6]Blue Sky Factory, Inc

 

Fwd: Faulty spindle checkpoint and cohesion protein activities predispose oocytes to premature chromosome separation and aneuploidy.



---------- Forwarded message ----------
From: HubMed - cancer <rssfwd@rssfwd.com>
Date: Wed, Jul 16, 2008 at 9:21 AM
Subject: Faulty spindle checkpoint and cohesion protein activities predispose oocytes to premature chromosome separation and aneuploidy.
To: mesothelioma77@gmail.com


[1]Environ Mol Mutagen. 2008 Jul 14;
Mailhes JB

Aneuploidy accounts for a major proportion of human reproductive failures, mental and physical anomalies, and neoplasms. To heighten our understanding of normal and abnormal chromosome segregation, additional information is needed about the underlying molecular mechanisms of chromosome segregation. Although many hypotheses have been proposed for the etiology of human aneuploidy, there has not been general acceptance of any specific hypothesis. Moreover, it is important to recognize that many potential mechanisms exist whereby chromosome missegregation may occur. One area for investigating aneuploidy centers on the biochemical changes that take place during oocyte maturation. In this regard, recent results have shown that faulty mRNA of spindle-assembly checkpoint proteins and chromosome cohesion proteins may lead to aneuploidy. Also, postovulatory and in vitro aging of mouse oocytes has been shown to lead to decreased levels of Mad2 transcripts and elevated frequencies of premature centromere separation. The intent of this review is to highlight the major events surrounding chromosome segregation and to present the published results that support the premise that faulty chromosome cohesion proteins and spindle checkpoint proteins compromise accurate chromosome segregation. Environ. Mol. Mutagen., 2008. (c) 2008 Wiley-Liss, Inc.



___
Source: http://www.hubmed.org/display.cgi?uids=18626998
--
 Powered by [5]RssFwd, a service of [6]Blue Sky Factory, Inc

 

Fwd: Serum vascular endothelial growth factor: a prognostic factor in cervical cancer.



---------- Forwarded message ----------
From: HubMed - cancer <rssfwd@rssfwd.com>
Date: Wed, Jul 16, 2008 at 9:21 AM
Subject: Serum vascular endothelial growth factor: a prognostic factor in cervical cancer.
To: mesothelioma77@gmail.com


[1]J Cancer Res Clin Oncol. 2008 Jul 15;
Zusterzeel PL, Span PN, Dijksterhuis MG, Thomas CM, Sweep FC, Massuger LF

PURPOSE: To study pre-treatment serum VEGF of patients with invasive cervical cancer and its possible role as prognostic indicator. METHODS: VEGF was measured using ELISA in the largest patient group (n = 167) to date. REULTS: Serum VEGF was significantly higher in advanced tumor stage (P = 0.01), large tumor size (tumors larger than 2 cm) (P = 0.03), and the presence of vascular space invasion (P = 0.05). Serum VEGF was associated with disease free and overall survival [DFS: Hazard Ratio (HR) = 2.61; 95% CI 1.32-5.17; P = 0.006; for OS: HR = 2.09; 95% CI 1.54-2.84; P

___
Source: http://www.hubmed.org/display.cgi?uids=18626660
--
 Powered by [5]RssFwd, a service of [6]Blue Sky Factory, Inc

 

Fwd: Erythropoiesis stimulating agents are associated with reduced survival in patients with multiple myeloma.



---------- Forwarded message ----------
From: HubMed - cancer <rssfwd@rssfwd.com>
Date: Wed, Jul 16, 2008 at 9:21 AM
Subject: Erythropoiesis stimulating agents are associated with reduced survival in patients with multiple myeloma.
To: mesothelioma77@gmail.com


[1]Am J Hematol. 2008 Jun 12;
Katodritou E, Verrou E, Hadjiaggelidou C, Gastari V, Laschos K, Kontovinis L, Kapetanos D, Constantinou N, Terpos E, Zervas K

The impact of erythropoiesis-stimulating agent (ESA) on cancer patients' survival has recently become a matter of extensive discussion. Studies in solid tumors demonstrated that ESA adversely affects survival. This issue has not been sufficiently studied in patients with multiple myeloma. In this study, which included 323 multiple myeloma patients followed in our Institution between 1988 and 2007, we demonstrated by using a proportional hazards model including multiple covariates (age, LDH, Hb, platelets, serum creatinine, ISS score, beta2 microglobulin, and ESA administration) that ESA administration is associated with reduced survival (hazards ratio: 1.88, 95% CI: 1.28-2.77). Anemia, which is considered a predictor for survival, platelets, serum creatinine, ISS score, and LDH, were not significant, whereas, age and beta2 microglobulin confirmed their predicting value in the multivariate analysis. With a median follow-up of 31 months (range 1-238), the median survival of patients in the ESA group was 31 months (95% CI: 25-37), whereas in the group without ESA administration it was 67 months (95% CI: 55-79) (P

___
Source: http://www.hubmed.org/display.cgi?uids=18626886
--
 ~
Powered by [5]RssFwd, a service of [6]Blue Sky Factory, Inc